Topics

Abeona Therapeutics Inc.: Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting

08:05 EDT 1 May 2019 | FinanzNachrichten

NEW YORK and CLEVELAND, May 01, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that intravitreal administratio...

Original Article: Abeona Therapeutics Inc.: Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting

NEXT ARTICLE

More From BioPortfolio on "Abeona Therapeutics Inc.: Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting"

Quick Search

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...